End-to-End Models to Imitate Traditional Chinese Medicine Syndrome Differentiation in Lung Cancer Diagnosis: Model Development and Validation

被引:25
|
作者
Liu, Ziqing [1 ,2 ]
He, Haiyang [3 ]
Yan, Shixing [3 ]
Wang, Yong [4 ]
Yang, Tao [2 ]
Li, Guo-Zheng [1 ]
机构
[1] Guangzhou Univ Chinese Med, Sch Clin Med 2, Guangzhou, Peoples R China
[2] Nanjing Univ Chinese Med, Sch Artif Intelligence & Informat Techol, Nanjing, Peoples R China
[3] Shanghai Bright AI Co Ltd, Shanghai, Peoples R China
[4] Shanghai Literature Inst Tradit Chinese Med, Shanghai, Peoples R China
基金
美国国家科学基金会;
关键词
traditional Chinese medicine; syndrome differentiation; lung cancer; medical record; deep learning; model fusion;
D O I
10.2196/17821
中图分类号
R-058 [];
学科分类号
摘要
Background: Traditional Chinese medicine (TCM) has been shown to be an efficient mode to manage advanced lung cancer, and accurate syndrome differentiation is crucial to treatment. Documented evidence of TCM treatment cases and the progress of artificial intelligence technology are enabling the development of intelligent TCM syndrome differentiation models. This is expected to expand the benefits of TCM to lung cancer patients. Objective: The objective of this work was to establish end-to-end TCM diagnostic models to imitate lung cancer syndrome differentiation. The proposed models used unstructured medical records as inputs to capitalize on data collected for practical TCM treatment cases by lung cancer experts. The resulting models were expected to be more efficient than approaches that leverage structured TCM datasets. Methods: We approached lung cancer TCM syndrome differentiation as a multilabel text classification problem. First, entity representation was conducted with Bidirectional Encoder Representations from Transformers and conditional random fields models. Then, five deep learning-based text classification models were applied to the construction of a medical record multilabel classifier, during which two data augmentation strategies were adopted to address overfitting issues. Finally, a fusion model approach was used to elevate the performance of the models. Results: The F1 score of the recurrent convolutional neural network (RCNN) model with augmentation was 0.8650, a 2.41% improvement over the unaugmented model. The Hamming loss for RCNN with augmentation was 0.0987, which is 1.8% lower than that of the same model without augmentation. Among the models, the text-hierarchical attention network (Text-HAN) model achieved the highest F1 scores of 0.8676 and 0.8751. The mean average precision for the word encoding-based RCNN was 10% higher than that of the character encoding-based representation. A fusion model of the text-convolutional neural network, text-recurrent neural network, and Text-HAN models achieved an F1 score of 0.8884, which showed the best performance among the models. Conclusions: Medical records could be used more productively by constructing end-to-end models to facilitate TCM diagnosis. With the aid of entity-level representation, data augmentation, and model fusion, deep learning-based multilabel classification approaches can better imitate TCM syndrome differentiation in complex cases such as advanced lung cancer.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Development of Improved Version of Quality of Life Assessment Instrument for Lung Cancer Patients Based on Traditional Chinese Medicine(QLASTCM-Lu)
    WANG Ting-ting
    HE Li-yun
    ZHANG Ming
    WANG Shao-mo
    ZHAO Ai-guang
    CHU Lei
    ZHANG Li-yuan
    YOU Sheng-fu
    YOU Jie
    Chinese Journal of Integrative Medicine , 2019, (11) : 831 - 836
  • [42] Development of Improved Version of Quality of Life Assessment Instrument for Lung Cancer Patients Based on Traditional Chinese Medicine (QLASTCM-Lu)
    Ting-ting Wang
    Li-yun He
    Ming Zhang
    Shao-mo Wang
    Ai-guang Zhao
    Lei Chu
    Li-yuan Zhang
    Sheng-fu You
    Jie You
    Chinese Journal of Integrative Medicine, 2019, 25 : 831 - 836
  • [43] Development of Improved Version of Quality of Life Assessment Instrument for Lung Cancer Patients Based on Traditional Chinese Medicine (QLASTCM-Lu)
    Wang Ting-ting
    He Li-yun
    Zhang Ming
    Wang Shao-mo
    Zhao Ai-guang
    Chu Lei
    Zhang Li-yuan
    You Sheng-fu
    You Jie
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2019, 25 (11) : 831 - 836
  • [44] Comparison of Efficacy and Toxicity of Traditional Chinese Medicine (TCM) Herbal Mixture LQ and Conventional Chemotherapy on Lung Cancer Metastasis and Survival in Mouse Models
    Zhang, Lei
    Wu, Chengyu
    Zhang, Yong
    Liu, Fang
    Wang, Xiaoen
    Zhao, Ming
    Hoffman, Robert M.
    PLOS ONE, 2014, 9 (10):
  • [45] Prediction Model for Lung Cancer in High-Risk Nodules Being Considered for Resection: Development and Validation in a Chinese Population
    Xia, Chunqiu
    Liu, Minghui
    Li, Xin
    Zhang, Hongbing
    Li, Xuanguang
    Wu, Di
    Ren, Dian
    Hua, Yu
    Dong, Ming
    Liu, Hongyu
    Chen, Jun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] Development and validation of risk prediction model for lung cancer in Chinese populations: A prospective cohort study of 0.5 million adults
    Zhu, Meng
    Song, Ci
    Ma, Hongxia
    Shen, Hongbing
    GENETIC EPIDEMIOLOGY, 2020, 44 (05) : 517 - 518
  • [47] Astragalus-containing Traditional Chinese Medicine, with and without prescription based on syndrome differentiation, combined with chemotherapy for advanced non-small-cell lung cancer: a systemic review and meta-analysis
    Wang, S. F.
    Wang, Q.
    Jiao, L. J.
    Huang, Y. L.
    Garfield, D.
    Zhang, J.
    Xu, L.
    CURRENT ONCOLOGY, 2016, 23 (03) : E188 - E195
  • [48] Development and validation of a predictive model for penile cancer based on the surveillance, epidemiology, and end results database and multi-center cases
    Yang, Shujun
    Chang, Wei
    Zhang, Bin
    Hou, Qian
    Zhang, Biao
    Kang, Yindong
    Yin, Yongsheng
    Wan, Jianghou
    Shang, Panfeng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (15) : 13665 - 13676
  • [49] Development and validation of a predictive model for penile cancer based on the surveillance, epidemiology, and end results database and multi-center cases
    Shujun Yang
    Wei Chang
    Bin Zhang
    Qian Hou
    Biao Zhang
    Yindong Kang
    Yongsheng Yin
    Jianghou Wan
    Panfeng Shang
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 13665 - 13676
  • [50] The development and evaluation of the traditional Chinese medicine (TCM) diagnosis scale of coronary heart disease (CHD) angina pectoris of spleen deficiency and phlegm turbid syndrome
    Zhang, Fan
    Xu, Yue
    Chen, Zhihui
    Liu, Yue
    Kong, Dezhao
    Pei, Yupeng
    Zhang, Shi
    Wang, Yang
    Zhang, Zhe
    Yang, Guanlin
    QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 87 - 87